The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation
Open accessAbstract
Summary CoV-GLUE is an online web application for the interpretation and analysis of SARS-CoV-2 virus genome sequences, with a focus on amino acid sequence variation. It is based on the GLUE data-centric bioinformatics environment and provides a browsable database of amino acid replacements and coding region indels that have been observed in sequences from the pandemic. Users may also analyse their own SARS-CoV-2 sequences by submitting them to the web application to receive an interactive report containing visualisations of phylogenetic classification and highlighting genomic variation of potentially high impact, for example linked to primer mismatches.Availability and implementation Available at http://cov-glue.cvr.gla.ac.uk. Implemented using GLUE, an open source framework for the development of virus sequence data resources. Contact josh.singer@glasgow.ac.uk
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They are frequently sensitive to mutation in these residues and select for K417N, E484K and N501Y mutations in SARS-CoV-2 S protein expression libraries in yeast and VSV 12,15,33.”
From mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) · cites this paper as [33]
In the citing paper
“Additionally, K417N, Y453F, S477R, N501Y, and D614G represent circulating variants some of which have been associated with rapidly increasing case numbers14,15,19,33–35.”
From mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) · cites this paper as [33]
In the citing paper
“A475V is resistant to class 1 antibodies (structurally defined as described29); E484K and Q493R are resistant to class 2 antibodies7,8,12,13,29,30,32,33; while R346S, N439K, and N440K are resistant to class 3 antibodies7,8,12,13,29,33.”
From mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) · cites this paper as [33]
Citations
Cites
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209
RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies
Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu033 · Cited by 32,291
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,745
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Amino Acid Difference Formula to Help Explain Protein Evolution
Grantham, R. L. (1974) · Science · doi:10.1126/science.185.4154.862 · Cited by 2,363
Nidovirales: Evolving the largest RNA virus genome
Gorbalenya, A. E., Enjuanes, L., Ziebuhr, J., & Snijder, E. J. (2006) · Virus Research · doi:10.1016/j.virusres.2006.01.017 · Cited by 938
A single amino acid in the PB2 gene of influenza A virus is a determinant of host range
Subbarao, K., London, W. T., & Murphy, B. R. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1761-1764.1993 · Cited by 936
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–167 of 167
Jeewandara, C., Guruge, D., Jayathilaka, D., Madhusanka, P. A. D., Pushpakumara, P. D., Ramu, S. T., Aberathna, I. S., Danasekara, D. R. S. R., Pathmanathan, T., Gunatilaka, B., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257548 · Cited by 10
Arévalo, M. T., Karavis, M. A., Katoski, S. E., Harris, J. V., Hill, J. M., Deshpande, S. V., Roth, P. A., Liem, A. T., & Bernhards, R. C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.910955 · Cited by 9
Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiologyPreprint
Hamed, S. M., Elkhatib, W. F., Khairallah, A. S., & Noreddin, A. M. (2020) · Research Square · doi:10.21203/rs.3.rs-89876/v1 · Cited by 10
VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis
Pinoli, P., Bernasconi, A., Sandionigi, A., & Ceri, S. (2021) · BioTech · doi:10.3390/biotech10040027 · Cited by 9
Xi, B., Jiang, D., Li, S., Lon, J. R., Bai, Y., Lin, S., Hu, M., Meng, Y., Qu, Y., Huang, Y., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.002 · Cited by 7
IDbSV: An Open-Access Repository for Monitoring SARS-CoV-2 Variations and Evolution
Essabbar, A., Kartti, S., Alouane, T., Hakmi, M., Belyamani, L., & Ibrahimi, A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.765249 · Cited by 8
Colson, P., Delerce, J., Burel, E., Beye, M., Fournier, P., Levasseur, A., Lagier, J., & Raoult, D. (2021) · Virus Genes · doi:10.1007/s11262-021-01877-2 · Cited by 9
Rajib, S. A., Ogi, Y., Hossain, M. B., Ikeda, T., Tanaka, E., Kawaguchi, T., & Satou, Y. (2021) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.01.019 · Cited by 8
Panzera, Y., Calleros, L., Goñi, N., Marandino, A. E., Techera, C., Grecco, S., Ramos, N., Frabasile, S., Tomás, G., Condon, E., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263563 · Cited by 8
Quispe-Ricalde, M. A., Castelán-Sánchez, H. G., Meza-Rodríguez, P. M., Dávila‐Ramos, S., Sierra, J. L., Batista‐García, R. A., Concha-Velasco, F., Lucana, S. F., Cruz, J. D. S., Zea, V., et al. (2023) · Archives of Virology · doi:10.1007/s00705-022-05645-x · Cited by 8
Bains, A., Guan, W., & LiWang, P. J. (2023) · Viruses · doi:10.3390/v15091901 · Cited by 9
Wang, C., Elghobashi‐Meinhardt, N., & Balch, W. E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.07.475295 · Cited by 9
Panzera, Y., Ramos, N., Calleros, L., Marandino, A. E., Tomás, G., Techera, C., Grecco, S., Frabasile, S., Fuques, E., Cóppola, L., et al. (2021) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760210275 · Cited by 7
Mziray, S. R., van Zwetselaar, M., Kayuki, C., Mbelele, P. M., Makubi, A. N., Magesa, A. S., Kisonga, R. M., Sonda, T., Kibiki, G. S., Githinji, G., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1034682 · Cited by 7
Garushyants, S. K., Rogozin, I. B., & Koonin, E. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.23.441209 · Cited by 8
An integrated multiscale computational framework deciphers SARS-CoV-2 resistance to sotrovimab
Sharma, A., Maurya, S., Kumar, S., Tripathi, T., Kar, R. K., & Padhi, A. K. (2025) · Biophysical Journal · doi:10.1016/j.bpj.2025.05.015 · Cited by 6
Rezaei, S., Pereira, F., Uversky, V. N., & Sefidbakht, Y. (2022) · Molecular Simulation · doi:10.1080/08927022.2022.2075546 · Cited by 6
Khamadi, S. A., Opanda, S. M., Symekher, S. L., Konongoi, S. L., Langat, S. K., Cirindi, J., Mwangi, M., Mwikwabe, N. M., Okeyo, S., Koskei, E., et al. (2022) · Virology Journal · doi:10.1186/s12985-022-01895-y · Cited by 6
COVID Variants, Villain and Victory: A Bioinformatics Perspective
Shukla, N., Srivastava, N., Gupta, R., Srivastava, P., & Narayan, J. (2023) · Microorganisms · doi:10.3390/microorganisms11082039 · Cited by 6
Soliman, M. S., AbdelFattah, M., Aman, S. M. N., Ibrahim, L. M., & Aziz, R. K. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0194 · Cited by 6
Padhi, A. K., & Tripathi, T. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp00171c · Cited by 6
CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants
Bukur, T., Riesgo-Ferreiro, P., Sorn, P., Gudimella, R., Hausmann, J., Rösler, T., Löwer, M., Schrörs, B., & Şahin, U. (2023) · Viruses · doi:10.3390/v15061391 · Cited by 5
Nyunt, M. H., Soe, H. O., Aye, K. T., Aung, W. W., Kyaw, Y. Y., Kyaw, A. K., Myat, T. W., Latt, A. Z., Win, M. M., Win, A. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89361-7 · Cited by 5
Xi, B., Meng, Y., Jiang, D., Bai, Y., Chen, Z., Qu, Y., Li, S., Wei, J., Huang, L., & Du, H. (2022) · Viruses · doi:10.3390/v14030454 · Cited by 5
ViralVar: A Web Tool for Multilevel Visualization of SARS-CoV-2 Genomes
Alisoltani, A., Jaroszewski, L., Godzik, A., Iranzadeh, A., Simons, L. M., Dean, T. J., Lorenzo-Redondo, R., Hultquist, J., & Ozer, E. A. (2022) · Viruses · doi:10.3390/v14122714 · Cited by 5
Coordinating SARS-CoV-2 genomic surveillance in the United States
Nelson, M. I., & Thielen, P. (2021) · Virus Evolution · doi:10.1093/ve/veab053 · Cited by 5
Tang, H., Ke, Y., Wang, L., Wu, M., Sun, T., & Zhu, J. (2022) · Pharmaceuticals · doi:10.3390/ph15081002 · Cited by 4
Garushyants, S., Rogozin, I. B., & Koonin, E. V. (2021) · Research Square · doi:10.21203/rs.3.rs-456574/v1 · Cited by 5
The Algerian Chapter of SARS-CoV-2 Pandemic: An Evolutionary, Genetic, and Epidemiological Prospect
Zeghbib, S., Somogyi, B. A., Zana, B., Kemenesi, G., Herczeg, R., Derrar, F., & Jakab, F. (2021) · Viruses · doi:10.3390/v13081525 · Cited by 4
Thomas, A. R., Battenfeld, T., Kraiselburd, I., Anastasiou, O. E., Dittmer, U., Dörr, A.-K., Dörr, A., Elsner, C., Gosch, J., Le‐Trilling, V. T. K., et al. (2024) · BMC Genomics · doi:10.1186/s12864-024-10539-0 · Cited by 4
Danda, M., Klimešová, A., Kušková, K., Dostálková, A., Pagáčová, A., Prchal, J., Kapisheva, M., Ruml, T., & Rumlová, M. (2024) · Protein Science · doi:10.1002/pro.5103 · Cited by 4
Spike Protein and the Various Cell-Surface Carbohydrates: An Interaction Study
Jayaprakash, N. G., & Surolia, A. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00691 · Cited by 4
LoTempio, J. E., Billings, E., Draper, K., Ralph, C., Moshgriz, M., Duong, N., Bard, J. D., Gai, X., WESSEL, D. L., DeBiasi, R. L., et al. (2021) · medRxiv · doi:10.1101/2021.02.08.21251344 · Cited by 4
Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, VietnamPreprint
Châu, N. V. V., Ngoc, N. M., Nguyet, L. A., Quang, V. M., Ny, N. T. H., Khoa, D. B., Phong, N. T., Toan, L. M., Hong, N. T. T., Tuyen, N. T. K., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3897733 · Cited by 4
Predicted binding interface between coronavirus nsp3 and nsp4Preprint
Hensel, Z. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.05.483145 · Cited by 5
Bioinformatics for the Origin and Evolution of Viruses
Chen, J., Zhang, Y., & Shen, B. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-8969-7_3 · Cited by 3
CoVEx: SARS-CoV-2 Mutation Explorer for genomic surveillance
Calderón-Osorno, M., Cordero-Laurent, E., & Duarte-Martínez, F. (2023) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2023.105521 · Cited by 3
Waman, V., Ashford, P., Lam, S. D., Sen, N., Abbasian, M., Woodridge, L., Goldtzvik, Y., Bordin, N., Wu, J., Sillitoe, I., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61541-1 · Cited by 7
Mutation Profile of SARS-CoV-2 Genome Sequences Originating from Eight Israeli Patient Isolates
Zaide, G., Cohen-Gihon, I., Israeli, O., Stein, D., Shifman, O., Weiss, S., Simon, I., Laskar, O., Beth-Din, A., & Zvi, A. (2021) · Microbiology Resource Announcements · doi:10.1128/mra.01387-20 · Cited by 3
Jahan, M., Bhattacharjee, A., Rahmat, R., Islam, S. M. R., Akhter, T., Ahammad, I., Hossain, M. U., Munshi, S. U., & Salimullah, M. (2021) · Microbiology Resource Announcements · doi:10.1128/mra.00496-21 · Cited by 3
SAS: A Platform of Spike Antigenicity for SARS-CoV-2
Zhang, L., Cao, R., Mao, T., Wang, Y., Lv, D., Yang, L., Tang, Y., Zhou, M., Ling, Y., Zhang, G., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.713188 · Cited by 3
Covidex: an ultrafast and accurate tool for virus subtypingPreprint
Cacciabue, M., Aguilera, P., Gismondi, M. I., & Taboga, O. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.21.261347 · Cited by 3
Role of FYVE and Coiled-Coil Domain Autophagy Adaptor 1 in severity of COVID-19 infectionPreprint
Smieszek, S. P., Przychodzen, B. P., Polymeropoulos, C. M., Polymeropoulos, V. M., & Polymeropoulos, M. H. (2021) · medRxiv · doi:10.1101/2021.01.22.21250070 · Cited by 3
In silico tracking of SARS-CoV-2 Nsp1 structural variants in helix-turn-helix motifPreprint
Rezaei, S., Pereira, F., & Sefidbakht, Y. (2021) · doi:10.22541/au.161659301.15541515/v1 · Cited by 3
Vaccine development strategies and impact
Nandi, A., Dey, Y. N., Maity, D., & Das, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95374-0.00015-4 · Cited by 2
Louis, I. V.-S., Gorzalski, A., & Pandori, M. (2021) · Applications of RNA-Seq in Biology and Medicine [Working Title] · doi:10.5772/intechopen.99156 · Cited by 3
CovRadar: Continuously tracking and filtering SARS-CoV-2 mutations for molecular surveillancePreprint
Wittig, A., Miranda, F. M., Hölzer, M., Altenburg, T., Bartoszewicz, J. M., Beyvers, S., Dieckmann, M. A., Genske, U., Giese, S. H., Nowicka, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.03.429146 · Cited by 2
Moore, C., Davies, L., Rees, R., Gifford, L., Lewis, H., Plimmer, A., Mack, A., Pacchiarini, N., Southgate, J., Bull, M. J., et al. (2021) · medRxiv · doi:10.1101/2021.03.22.21254006 · Cited by 2
Oliver, J. L. T., Bernaola‐Galván, P., Perfectti, F., Gómez‐Martín, C., Castiglione, S., Raia, P., Verdú, M., & Moya, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.06.467547 · Cited by 2
Identifying stable-against-mutations viral epitopes in SARS-CoV-2Preprint
la Fuente, I. M. D., Malaina, I., Fedetz, M., Chruszcz, M., Grandes, G., Targoni, O. S., Pérez, A. A. L., Shteyer, E., Yaʼacov, A. B., de la Cámara, A. G., et al. (2022) · medRxiv · doi:10.1101/2022.10.13.22280980 · Cited by 2
Gu, S., Bentley, E. G., Milligan, R., Almuqrin, A., Sharma, P., Kirby, A., Mega, D. F., Kipar, A., Erdmann, M., Bazire, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.04.551973 · Cited by 2
Hassan, D. A., Maulud, S. Q., Rashid, R. F., Ahmed, J. Q., & Ali, R. K. (2024) · BioMed Target Journal · doi:10.59786/bmtj.213 · Cited by 1
Predicting the trend of SARS-CoV-2 mutation frequencies using historical data
Zhou, X., Yan, Y., Hu, K., Tang, H.-X., Wang, Y.-J., Wang, L., Zhang, C., & Cao, S. (2025) · Bioinform. · doi:10.1093/bioinformatics/btaf508 · Cited by 1
Databases, DrugBank, and virtual screening platforms for therapeutic development
Middha, S. K., David, A., Haldar, S., Boro, H., Panda, P., Bajare, N., Milesh, L., Devaraj, V., & Usha, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91172-6.00021-2 · Cited by 2
Kovalenko, A., & Viatte, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1356314 · Cited by 1
Cross-Species Susceptibility of Emerging Variants of SARS-CoV-2 Spike
Li, M., Lv, F., Li, Z., Zhao, C., Wang, X., Zhu, P., & Zhou, X. (2024) · Genes · doi:10.3390/genes15101321 · Cited by 1
In silico framework for genome analysis
Nawaz, M. S., Nawaz, M. Z., Gong, Y., Fournier‐Viger, P., & Diallo, A. B. (2024) · Future Generation Computer Systems · doi:10.1016/j.future.2024.107585 · Cited by 1
VITALdb: to select the best viroinformatics tools for a desired virus or application
Koul, M., kaushik, S., Singh, K., & Sharma, D. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf084 · Cited by 1
Update on the First Year of COVID-19 (First Year of COVID-19)?
Kilbaş, E. P. K., Altındiş, M., Yılancıoğlu, K., Tekin, İ. Ö., Buran, D., Özkan, S., Şener, A., & ILHAN, M. N. (2021) · Mediterranean Journal of Infection Microbes and Antimicrobials · doi:10.4274/mjima.galenos.2021.2021.44 · Cited by 1
Molecular Dynamics of SARS-CoV-2 Nsp1 Structural Changes Associated with Variant MutationsPreprint
Rezaei, S., Sefidbakht, Y., & Pereira, F. (2021) · Research Square · doi:10.21203/rs.3.rs-781636/v1
Vavougios, G. D., Zarogiannis, S. G., & Gourgoulianis, K. I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91794-0.00022-6
Publicly available resources in COVID-19 research and their applications
Baralić, K., Živančević, K., Božić, D., & Đukić-Ćosić, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91794-0.00017-2
Waman, V., Ashford, P., Lam, S. D., Sen, N., Abbasian, M., Woodridge, L., Goldtzvik, Y., Bordin, N., Wu, J., Sillitoe, I., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.07.566012
Conceptual Modeling for Bioinformatics
Bernasconi, A., & Alberto García, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95502-7.00003-8
Sharmila, A., & Selvaraj, C. I. (2025) · Critical Public Health · doi:10.1080/09581596.2025.2606437
Analyse du cycle du SARS-CoV-2 en modèle cellulaire par microscopie électronique à transmission
Eymieux, S. (2023) · theses.fr (ABES) · doi:10.70675/b2613d6dz2a78z4ce7za880z900e0b790d14
FAIRsharing record for: ViruSurf
FAIRsharing Team, Canakoglu, A., & Canakoglu, A. (2018) · FAIRsharing.org · doi:10.25504/fairsharing.vx5oev
Metadata
- Authors
- Singer, J., Gifford, R., Cotten, M., & Robertson, D.
- Affiliations
- MRC University of Glasgow Centre for Virus Research (GB)
- Corresponding author
- Singer, Joshua
- Venue
- Preprints.org
- Publisher
- MDPI AG
- Published
- 2020-06-18
- OpenAlex
- W3035920796
- Cited by
- 167
- References
- 25
- Citations by year
- 2025: 5 · 2024: 10 · 2023: 16 · 2022: 30 · 2021: 85 · 2020: 21
- Type
- posted content
- Language
- en
- Open access
- green
- doi.org
- Locations
- Preprints.org (acceptedVersion, cc-by)
- Funders
- Wellcome Trust (220977/Z/20/Z)
- UK Research and Innovation (MC_PC_19027)
- Department of Health and Social Care
- Department for International Development
- Medical Research Council (MC_PC_19027, MC UU 12014/12, COVID-19)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, genomic variation, amino acid substitutions, indels, viral genome sequence, phylogenetic classification, primer mismatch, web application, COVID-19 pandemic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review